Clincosm LogoSign in Get a demo

nasopharyngeal neoplasms

Showing 1 - 25 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharyngeal Tumors Trial in Germany (drug, radiation, procedure, behavioral)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Aachen, Germany
  • +28 more
Aug 24, 2023

Nasopharyngeal Tumors Trial (The combination treatment of anlotinib, penpulimab and capecitabine.)

Not yet recruiting
  • Nasopharyngeal Neoplasms
  • The combination treatment of anlotinib, penpulimab and capecitabine.
  • (no location specified)
Apr 10, 2023

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 3, 2022

Nasopharyngeal Tumors Trial in China (Sintilimab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Nasopharyngeal Neoplasms
  • Foshan, Guangdong, China
  • +8 more
Oct 6, 2022

Nasopharyngeal Tumors Trial in China (Camrelizumab)

Recruiting
  • Nasopharyngeal Neoplasms
  • Foshan, Guangdong, China
  • +10 more
May 3, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (gemcitabine and cisplatin,

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • gemcitabine and cisplatin
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 4, 2022

Nasopharyngeal Tumors Trial in Guangzhou (gemcitabine and cisplatin, 5-Fluorouracil and cisplatin)

Completed
  • Nasopharyngeal Neoplasms
  • gemcitabine and cisplatin
  • 5-Fluorouracil and cisplatin
  • Guangzhou, Guangdong, China
    Department of Medical Oncology,Cancer Center of Sun Yat-Sen Univ
Sep 27, 2021

Nasopharyngeal Tumors Trial in Guangzhou (Tis-U-Sol)

Not yet recruiting
  • Nasopharyngeal Neoplasms
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital & Institute of Guangzhou Medical Univ
Jun 3, 2021

Family Study of Head and Neck Cancers in Taiwan

Completed
  • Nasopharyngeal Neoplasms
  • Herpesvirus 4, Human
    • Taipei, Taiwan, China
      National Taiwan University College of Medicine
    Dec 10, 2020

    Nasopharyngeal Tumors Trial (Toripalimab, Albumin-bound Paclitaxel, Cisplatin)

    Not yet recruiting
    • Nasopharyngeal Neoplasms
    • (no location specified)
    Jun 23, 2020

    Nasopharyngeal Tumors Trial (endostar, intensity modulated radiation, cisplatin)

    Completed
    • Nasopharyngeal Neoplasms
    • (no location specified)
    Jun 22, 2020

    Nasopharyngeal Tumors Trial in Guangzhou (IMRT using individualized CTV, IMRT using traditional CTV, Gemcitabine and cisplatin

    Unknown status
    • Nasopharyngeal Neoplasms
    • IMRT using individualized CTV
    • +5 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jun 13, 2020

    Environmental and Genetic Determinants of NPC

    Terminated
    • Nasopharyngeal Neoplasms
    • Herpesvirus 4, Human
      • Taipei City, Taiwan
      • +5 more
      Jun 3, 2020

      Identify Individuals Susceptible to Nasopharyngeal Carcinoma

      Terminated
      • Nasopharyngeal Neoplasms
        • Taiwan, China
          National Taiwan University
        Jun 3, 2020

        Nasopharyngeal Tumors, Mortality, Quality of Life Trial in Guangzhou (Hyperfractionated IMRT, Conventional Fraction IMRT)

        Active, not recruiting
        • Nasopharyngeal Neoplasms
        • +3 more
        • Hyperfractionated IMRT
        • Conventional Fraction IMRT
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Mar 21, 2020

        Nasopharyngeal Tumors Trial in Toronto (intensity modulated radiation therapy, cisplatinium and fluorouracil - standard

        Completed
        • Nasopharyngeal Neoplasms
        • intensity modulated radiation therapy
        • cisplatinium and fluorouracil - standard treatment
        • Toronto, Ontario, Canada
          Princess Margaret Hospital
        Nov 28, 2019

        Nasopharyngeal Tumors Trial in Changsha (Endostar)

        Unknown status
        • Nasopharyngeal Neoplasms
        • Changsha, Hunan, China
          the Second Xiangya Hospital
        Jan 29, 2019

        Nasopharyngeal Tumors Trial in Worldwide (CC-486)

        Completed
        Has Results
        • Nasopharyngeal Neoplasms
        • Atlanta, Georgia
        • +24 more
        Nov 20, 2018

        Nasopharyngeal Tumors Trial in Guangzhou (Sintilimab, Gemcitabine, Cisplatin)

        Not yet recruiting
        • Nasopharyngeal Neoplasms
        • Guangzhou, Guangdong, China
          SUN YAT-SEN UNIVERSITY cANCER CENTER
        Oct 6, 2018

        Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count

        Recruiting
        • Nasopharyngeal Neoplasms
        • +3 more
          • Bengbu, Anhui, China
          • +5 more
          Jun 18, 2018

          Colorectal Tumors, Urologic Tumors, Urologic Diseases Trial in Hong Kong (Robotic single port surgery and NOTES)

          Completed
          • Colorectal Neoplasms
          • +8 more
          • Robotic single port surgery and NOTES
          • Hong Kong, China
            Prince of Wales Hospital, The Chinese University of Hong Kong
          Feb 5, 2018

          Nasopharyngeal Tumors, Salivary Gland Diseases, Bone Marrow Diseases Trial in Guangzhou (Amifostine every-other-day regimen,

          Unknown status
          • Nasopharyngeal Neoplasms
          • +3 more
          • Amifostine every-other-day regimen
          • Amifostine everyday regimen
          • Guangzhou, Guangdong, China
          • +6 more
          Jul 11, 2017

          Predictive Factors of Acute Oral Mucositis Induced by

          Unknown status
          • Nasopharyngeal Neoplasms
          • Stomatitis
            • Hangzhou, Zhejiang, China
              Zhejiang Cancer Hospital
            Jun 27, 2017

            Nasopharyngeal Tumors Trial in Chendu (Apatinib)

            Unknown status
            • Nasopharyngeal Neoplasms
            • Chendu, Sichuan, China
              Sichuan Cancer Hospital
            Jun 12, 2017

            Nasopharyngeal Tumors Trial in Guangzhou (adverse events using patient-reported outcomes version of common terminology criteria

            Unknown status
            • Nasopharyngeal Neoplasms
            • adverse events using patient-reported outcomes version of common terminology criteria for adverse events (PRO-CTCAE) questionaire
            • do not report adverse events through patient-reported outcomes version of common terminology criteria for adverse events (PRO-CTCAE) questionaire
            • Guangzhou, Guangdong, China
              Sun Yat-sen University Cancer Center
            Mar 22, 2017